(Q34225721)

English

Antioxidant therapy for chronic hepatitis C after failure of interferon: results of phase II randomized, double-blind placebo controlled clinical trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Antioxidant therapy for chronic hepatitis C after failure of interferon: results of phase II randomized, double-blind placebo controlled clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

phase II clinical trial

0 references

0 references

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

1

object named as

Ezra Gabbay

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

2

object named as

Ehud Zigmond

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Orit Pappo

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Nila Hemed

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Mina Rowe

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

George Zabrecky

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Robert Cohen

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Yaron Ilan

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

1 October 2007

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

World Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

40

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

5317-5323

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Chronic hepatitis C virus management: 2000-2005 update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171320

28 July 2018

Molecular basis of hepatitis C virus-associated hepatocarcinogenesis: lessons from animal model studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171320

28 July 2018

Current and future concepts in hepatitis C therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171320

28 July 2018

Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171320

28 July 2018

Expression of gastrointestinal glutathione peroxidase is inversely correlated to the presence of hepatitis C virus subgenomic RNA in human liver cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171320

28 July 2018

Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171320

28 July 2018

Medicinal herbs for hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171320

28 July 2018

Complementary and alternative medicine in chronic liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171320

28 July 2018

Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171320

28 July 2018

Pharmacokinetics of intravenous glycyrrhizin after single and multiple doses in patients with chronic hepatitis C infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171320

28 July 2018

Alpha-lipoic acid in liver metabolism and disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171320

28 July 2018

Alpha-glutathione transferases in HCV-related chronic hepatitis: a new predictive index of response to interferon therapy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171320

28 July 2018

Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171320

28 July 2018

Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171320

28 July 2018

Pharmacological actions and clinical use of fructus schizandrae

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171320

28 July 2018

Oxidative stress and hepatitis C viral infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171320

28 October 2018

Treatment of chronic hepatitis C virus infection via antioxidants: results of a phase I clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171320

28 October 2018

Medicinal herbs for hepatitis C virus infection: a Cochrane hepatobiliary systematic review of randomized trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171320

28 October 2018

Interferon/antioxidant combination therapy for chronic hepatitis C--a controlled pilot trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171320

28 October 2018

A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171320

28 October 2018

The long term efficacy of glycyrrhizin in chronic hepatitis C patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171320

28 October 2018

Intravenous glycyrrhizin for the treatment of chronic hepatitis C: A double‐blind, randomized, placebo‐controlled phase I/II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17879400

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pilot study on the liver protective effect of silybin-phosphatidylcholine complex (IdB1016) in chronic active hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17879400

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of oxidative stress based on lipid hydroperoxide, vitamin C and vitamin E during apoptosis and necrosis caused by thioacetamide in rat liver

1 reference

https://pubmed.ncbi.nlm.nih.gov/17879400

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of silymarin on chemical, functional, and morphological alterations of the liver. A double-blind controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17879400

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver

1 reference

https://pubmed.ncbi.nlm.nih.gov/17879400

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of interferon, glycyrrhizin combination therapy in patients with chronic hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/17879400

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Silymarin protects against paracetamol-induced lipid peroxidation and liver damage

1 reference

https://pubmed.ncbi.nlm.nih.gov/17879400

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3748/WJG.V13.I40.5317

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34225721&oldid=1993640703"